Subclinical systemic inflammation contributes to the etiology of insulin resistance (Kolb, 2005), which may explain the increased diabetes risk associated with elevated CRP concentrations prospectively (Pradhan et al., 2001). This evidence concerns the gene CRP and diabetes mellitus.